In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Daniel McIver spoke about the challenges and rewards of his ...

The burgeoning field of transthyretin amyloid cardiomyopathy (ATTR-CM), which spurred excitement over a potential $20 billion ...

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...

Lawmakers are proposing a new effort to strengthen biopharma manufacturing in the U.S., leveraging a bill that seeks to ...

Incyte is strutting its stuff to boost awareness and support for people with vitiligo—with help from supermodel Winnie Harlow ...

Back in August, the FDA announced that it was working on a new program dubbed FDA PreCheck, which broadly aims to improve ...

The U.S. House of Representatives has given a unanimous thumbs up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December ...

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...

In this episode of Health Matters, GCI Health’s Ryan Kuresman and Health@WPP’s Wendy Lund explore the fast-shifting landscape ...

Following the deal’s Nov. 26 close, Omnicom on Monday outlined the structure of the newly combined company, including leaders ...

The Trump administration has lined up another country-specific trade agreement, this time with the U.K., which confers Washington’s biggest break on pharmaceutical import tariffs yet. | The Trump ...